By John W.M. Claud & Michelle L. Butler — Recent reductions in force (RIFs) and leadership...
Author - David Miller
CRISPR’s CEO got a big payday
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech...
Una señal de que tu pez podría estar drogado: se arriesga más
Los investigadores que estudian la contaminación farmacéutica rastrearon salmones que habían...
Akeso’s PD-1/VEGF Bispecific Antibody Demonstrates Meaningful...
In the Phase III HARMONi-6 trial, ivonescimab plus chemotherapy significantly outperformed...
Industry Outlook 2025: Mergers, Acquisitions, and Funding
Pharmaceutical Technology® Group spoke with Erik Wiklund, CEO of Circio, about the future of M&A...
UK Cuts Tariffs on Dozens of Products as Global Trade Tensions...
British officials also announced more financing for exporters as the country sought to protect...
Many young people want to quit vaping. A new study says...
The young people who wanted to quit e-cigarettes didn’t necessarily think they were addicted. But...
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease...
The project, the North African Dementia Registry, will unite multiple entities for the purpose of...
RFK Jr. Accuses FDA of Drug Industry Influence That Barred...
The nation’s health secretary addressed agency employees, asking them to shed any corporate...
What To Do When You Receive a DEA Order to Show Cause
By Andrew J. Hull — We published a version of this post several years back (see here), but recent...